Streetbeat News

Equity Actions

KMB

Kimberly-Clark (NYSE:KMB) has received mixed analyst ratings over the past three months, with a recent shift towards a more bullish outlook. The average 12-month price target is now $125.00, a slight decrease from the previous $127.50. Analyst actions include maintaining, raising, and lowering ratings and price targets, reflecting varied perceptions of the company's market position. Kimberly-Clark, known for its personal care and consumer tissue products, shows a positive revenue trend but lags in revenue growth compared to industry peers. Its financials indicate strong profitability and effective cost management, though it faces challenges in efficiently using equity capital.

Portfolio Pulse from Benzinga Insights

March 01, 2024 | 12:00 pm

DTIL

Precision BioSciences announced a $40M offering of common stock and warrants, with warrants exercisable immediately at $20.00 per share.

Portfolio Pulse from Benzinga Newsdesk

March 01, 2024 | 11:40 am

TNC

Tennant Company (NYSE:TNC) has acquired M&F Management and Financing, the parent company of TCS EMEA, to expand its presence in Eastern Europe and the EMEA region. This strategic move aims to leverage TCS's established network in countries like Romania, Hungary, the Czech Republic, Slovakia, Austria, Switzerland, Poland, and others, as well as in the Middle East and Africa, to enhance Tennant's global sales and service network.

Portfolio Pulse from Nabaparna Bhattacharya

March 01, 2024 | 10:53 am

KDP

Keurig Dr Pepper (KDP) has announced the pricing of up to 100 million common shares at $29.10 each by JAB. KDP plans to repurchase 35 million shares as part of this offering, under its $4 billion repurchase authorization, leaving approximately $1.8 billion remaining. Post-offering, JAB will own about 21% of KDP's outstanding stock, increasing KDP's public float to roughly 79%.

Portfolio Pulse from Benzinga Newsdesk

March 01, 2024 | 8:50 am

APG

BX

APi Group Corporation (NYSE:APG) announced an upsized secondary public offering of 10,569,106 shares at $34.25/share, initiated by Blackstone Inc. and Viking Global Investors LP. The shares were offered by the Selling Stockholders, who received them upon conversion of 5.5% Series B Perpetual Convertible Preferred Stock.

Portfolio Pulse from Benzinga Newsdesk

March 01, 2024 | 8:33 am

CCCS

CCC Intelligent Solutions has upsized its secondary offering to 43 million shares at $11.42 each, with an option for underwriters to buy an additional 6.45 million shares. The offering is expected to close by March 4, 2024.

Portfolio Pulse from Benzinga Newsdesk

March 01, 2024 | 8:31 am

HUMA

Humacyte has announced a public offering of 13.4 million shares of common stock priced at $3 per share, totaling $40.2 million. The proceeds will be used to advance its regenerative medicine pipeline, support FDA review of its Biologics License Application for bioengineered human acellular vessels for urgent arterial repair, establish initial commercial infrastructure, and for general corporate purposes.

Portfolio Pulse from Benzinga Newsdesk

March 01, 2024 | 8:08 am

CLDX

Celldex Therapeutics has announced an upsized public offering of 8.52 million shares at $47 per share, expecting to raise approximately $400.4 million. The offering includes an option for underwriters to purchase up to an additional 1.278 million shares and is expected to close around March 5, 2024.

Portfolio Pulse from Benzinga Newsdesk

March 01, 2024 | 8:06 am

SIDU

Sidus Space announced a public offering of 1,321,000 Class A common shares at $6/share, aiming to use the proceeds for working capital and general corporate purposes. The offering is expected to close on March 5, 2024.

Portfolio Pulse from Benzinga Newsdesk

March 01, 2024 | 7:54 am

TSLX

Sixth Street Specialty Lending (TSLX) has announced a public offering of 4 million shares, aiming to raise $83.4M in gross proceeds. The underwriters have an option to purchase an additional 600,000 shares. The offering, expected to close around March 5, 2024, will fund debt repayment and new investments per the company's objectives.

Portfolio Pulse from Benzinga Newsdesk

March 01, 2024 | 7:40 am